|
Market Closed -
Canadian Securities Exchange
19:13:48 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.005000 CAD | 0.00% |
|
0.00% | -66.67% |
| Market Cap | 671K 479K 428K 395K 358K 45.48M 682K 4.76M 1.88M 23.81M 1.8M 1.76M 75.15M | P/E 2024 |
-1.31x | P/E 2025 | -4.23x |
|---|---|---|---|---|---|
| Enterprise Value | 2.17M 1.55M 1.38M 1.28M 1.16M 147M 2.21M 15.39M 6.08M 77.07M 5.82M 5.7M 243M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
77.22% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| PHRX | Delayed | |
OTC Markets
| LMLLF | Delayed | |
|
Deutsche Boerse AG
| G11 | Delayed | |
|
Boerse Muenchen
| G11 | Real-time |
| 3 months | -50.00% | ||
| 6 months | -50.00% | ||
| Current year | -66.67% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.02 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.08 |
| 5 years | 0 | | 0.46 |
| 10 years | 0 | | 4.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyle Appleby
DFI | Director of Finance/CFO | 50 | 20/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul McClory
BRD | Director/Board Member | 82 | 20/12/2016 |
David Kideckel
CHM | Chairman | - | 27/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/14/25 A | Other | Chairman | 1,380,000 | 1.2929% | ||
| 5/3/24 A | Other | Director | 0 | 0% | ||
| 5/3/24 A | Option | Director | 500,000 | 0.5718% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -50.00% | -85.71% | 478K | |
| -2.54% | +1.75% | +56.75% | +117.82% | 1,165B | |
| -1.42% | +4.16% | +36.73% | +72.42% | 645B | |
| +0.16% | +0.79% | +24.91% | +95.34% | 504B | |
| -0.31% | +2.95% | +39.36% | +63.56% | 380B | |
| -1.34% | +0.06% | +65.81% | +41.49% | 363B | |
| -0.68% | +1.67% | +22.07% | +50.94% | 297B | |
| -1.20% | +0.99% | +2.26% | +22.95% | 269B | |
| -1.79% | +1.20% | +48.41% | +57.55% | 237B | |
| -0.73% | -0.85% | +28.47% | +100.57% | 195B | |
| Average | -0.80% | +2.29% | +27.48% | +53.69% | 405.55B | |
| Weighted average by Cap. | -0.74% | +3.17% | +40.78% | +80.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -793K -566K -506K -467K -424K -53.77M -806K -5.62M -2.22M -28.15M -2.13M -2.08M -88.83M | -383K -274K -244K -226K -205K -25.98M -389K -2.72M -1.07M -13.6M -1.03M -1.01M -42.93M |
| Net Debt | 1.27M 909K 812K 750K 680K 86.34M 1.29M 9.03M 3.57M 45.21M 3.41M 3.34M 143M | 1.5M 1.07M 957K 884K 801K 102M 1.52M 10.63M 4.2M 53.26M 4.02M 3.94M 168M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | CA$0.005000 | 0.00% | 7,000 |
| 22/10/26 | CA$0.005000 | 0.00% | 5,000 |
| 21/10/26 | CA$0.005000 | 0.00% | 20,682 |
| 20/10/26 | CA$0.005000 | 0.00% | 1,035 |
| 19/10/26 | CA$0.005000 | 0.00% | 3,464 |
- Stock Market
- Stocks
- PHRX Stock
Select your edition
All financial news and data tailored to specific country editions
